326 related articles for article (PubMed ID: 35900649)
1. Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments.
Vander Does A; Levy C; Yosipovitch G
Am J Clin Dermatol; 2022 Sep; 23(5):647-659. PubMed ID: 35900649
[TBL] [Abstract][Full Text] [Related]
2. MRGPRX4 in Cholestatic Pruritus.
Yu H; Wangensteen K; Deng T; Li Y; Luo W
Semin Liver Dis; 2021 Aug; 41(3):358-367. PubMed ID: 34161994
[TBL] [Abstract][Full Text] [Related]
3. Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study.
Baumann U; Sturm E; Lacaille F; Gonzalès E; Arnell H; Fischler B; Jørgensen MH; Thompson RJ; Mattsson JP; Ekelund M; Lindström E; Gillberg PG; Torfgård K; Soni PN
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101751. PubMed ID: 34182185
[TBL] [Abstract][Full Text] [Related]
4. Potential of ileal bile acid transporter inhibition as a therapeutic target in Alagille syndrome and progressive familial intrahepatic cholestasis.
Kamath BM; Stein P; Houwen RHJ; Verkade HJ
Liver Int; 2020 Aug; 40(8):1812-1822. PubMed ID: 32492754
[TBL] [Abstract][Full Text] [Related]
5. Cholestatic pruritus : an update.
De Vloo C; Nevens F
Acta Gastroenterol Belg; 2019; 82(1):75-82. PubMed ID: 30888758
[TBL] [Abstract][Full Text] [Related]
6. MRGPRX4 is a G protein-coupled receptor activated by bile acids that may contribute to cholestatic pruritus.
Meixiong J; Vasavda C; Snyder SH; Dong X
Proc Natl Acad Sci U S A; 2019 May; 116(21):10525-10530. PubMed ID: 31068464
[TBL] [Abstract][Full Text] [Related]
7. Safety considerations for the management of cholestatic itch.
Trivella J; Levy C
Expert Opin Drug Saf; 2021 Aug; 20(8):915-924. PubMed ID: 33836644
[No Abstract] [Full Text] [Related]
8. Mechanisms of pruritus in cholestasis: understanding and treating the itch.
Beuers U; Wolters F; Oude Elferink RPJ
Nat Rev Gastroenterol Hepatol; 2023 Jan; 20(1):26-36. PubMed ID: 36307649
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and Management of Pruritus in PBC and PSC.
Kremer AE; Namer B; Bolier R; Fischer MJ; Oude Elferink RP; Beuers U
Dig Dis; 2015; 33 Suppl 2():164-75. PubMed ID: 26641452
[TBL] [Abstract][Full Text] [Related]
10. Serum Autotaxin Activity Correlates With Pruritus in Pediatric Cholestatic Disorders.
Kremer AE; Gonzales E; Schaap FG; Oude Elferink RP; Jacquemin E; Beuers U
J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):530-5. PubMed ID: 26628447
[TBL] [Abstract][Full Text] [Related]
11. [Cholestatic pruritus : new insights into pathophysiology and current treatment].
Kremer AE; Oude Elferink RP; Beuers U
Hautarzt; 2012 Jul; 63(7):532-8. PubMed ID: 22733242
[TBL] [Abstract][Full Text] [Related]
12. [Cholestatic pruritus--pathophysiology and therapy with special reference to treatment with 5-hydroxytryptamine subtype 3 receptor antagonists].
Schwörer H; Ramadori G
Z Gastroenterol; 1995 May; 33(5):265-74. PubMed ID: 7610695
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Cholestasis in Infants and Young Children.
Heinz N; Vittorio J
Curr Gastroenterol Rep; 2023 Nov; 25(11):344-354. PubMed ID: 37651067
[TBL] [Abstract][Full Text] [Related]
14. Mediators of pruritus during cholestasis.
Oude Elferink RP; Kremer AE; Beuers U
Curr Opin Gastroenterol; 2011 May; 27(3):289-93. PubMed ID: 21451412
[TBL] [Abstract][Full Text] [Related]
15. Cholestatic Itch Management.
Mittal A
Curr Probl Dermatol; 2016; 50():142-8. PubMed ID: 27578083
[TBL] [Abstract][Full Text] [Related]
16. Cholestatic Pruritus in Children: Conventional Therapies and Beyond.
Rodrigo M; Dong X; Chien D; Karnsakul W
Biology (Basel); 2023 May; 12(5):. PubMed ID: 37237568
[TBL] [Abstract][Full Text] [Related]
17. Odevixibat: a promising new treatment for progressive familial intrahepatic cholestasis.
Bedoyan SM; Lovell OT; Horslen SP; Squires JE
Expert Opin Pharmacother; 2022 Nov; 23(16):1771-1779. PubMed ID: 36278881
[TBL] [Abstract][Full Text] [Related]
18. Cholestatic pruritus: Emerging mechanisms and therapeutics.
Patel SP; Vasavda C; Ho B; Meixiong J; Dong X; Kwatra SG
J Am Acad Dermatol; 2019 Dec; 81(6):1371-1378. PubMed ID: 31009666
[TBL] [Abstract][Full Text] [Related]
19. Development of the Patient- and Observer-Reported PRUCISION Instruments to Assess Pruritus and Sleep Disturbance in Pediatric Patients with Cholestatic Liver Diseases.
Gwaltney C; Bean S; Venerus M; Karlsson L; Warholic N; Kjems L; Horn P
Adv Ther; 2022 Nov; 39(11):5126-5143. PubMed ID: 36066744
[TBL] [Abstract][Full Text] [Related]
20. Pruritus in cholestasis: facts and fiction.
Beuers U; Kremer AE; Bolier R; Elferink RP
Hepatology; 2014 Jul; 60(1):399-407. PubMed ID: 24807046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
